세계의 정맥 내(IV) 수액 요법 시장 : 산업 규모, 점유율, 동향, 기회 및 예측 - 서비스별, 성분별, 최종 이용 산업별, 지역별, 경쟁별(2020-2030년)
Intravenous Hydration Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Component, By End-Use Industry, By Region and Competition, 2020-2030F
정맥 내(IV) 수액 요법 세계 시장은 2024년에 32억 6,000만 달러로 평가되었으며, 예측 기간 동안 7.32%의 연평균 복합 성장률(CAGR)로 성장하여 2030년까지 49억 8,000만 달러에 달할 것으로 예상됩니다.
정맥 내(IV) 수액 요법은 정맥을 통해 사람의 혈류에 직접 수분, 전해질, 경우에 따라서는 약물을 주입하는 치료법입니다. 일반적으로 탈수 및 다양한 질환에 대처하기 위해 사용됩니다. 수액 주입은 질병, 과다 발한, 구토, 설사, 수분 섭취 부족 등으로 인한 중등도에서 중증의 탈수증을 치료하기 위해 시행되는 경우가 많습니다. 정맥주사는 체내 수분을 빠르게 보충하여 전해질 균형을 회복하고 적절한 장기 기능을 유지하도록 돕습니다. 정맥주사 요법은 위장염, 신장 감염, 요로 감염 등 특정 질환으로 인한 체액 및 전해질 불균형을 관리하는 데 도움이 될 수 있습니다. 전해질은 필수 미네랄(나트륨, 칼륨, 칼슘, 마그네슘 등)로 신경 및 근육 기능, 체액 균형, pH 조절 등 다양한 신체 기능 유지에 중요한 역할을 합니다. 정맥 수액 요법은 신장 기능 장애, 호르몬 장애, 심한 구토 및 설사 등의 질환으로 인한 전해질 불균형을 교정할 수 있습니다.
| 시장 개요 |
| 예측 기간 |
2026-2030년 |
| 시장 규모 : 2024년 |
32억 6,000만 달러 |
| 시장 규모 : 2030년 |
49억 8,000만 달러 |
| CAGR : 2025-2030년 |
7.32% |
| 급성장 부문 |
의약품 부문 |
| 최대 시장 |
북미 |
주요 시장 성장 촉진요인
수술 절차 증가가 시장 성장을 주도
주요 시장 과제
규제 및 법적 고려사항
주요 시장 동향
웰빙 및 라이프스타일 용도 증가
목차
제1장 제품 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 정맥내(IV) 수분 보급 요법 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 서비스별(면역력 업, 에너지 업, 스킨케어, 편두통, 기타)
- 성분별(의약품, 의약품 이외)
- 최종 이용 산업별(병원 및 클리닉, 웰니스 센터 및 스파, 재택 헬스케어, 기타)
- 기업별(2024년)
- 지역별
- 시장 맵
제6장 북미의 정맥내(IV) 수분 보급 요법 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 북미 : 국가별 분석
제7장 유럽의 정맥내(IV) 수분 보급 요법 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 유럽 : 국가별 분석
제8장 아시아태평양의 정맥내(IV) 수분 보급 요법 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 아시아태평양 : 국가별 분석
제9장 남미의 정맥내(IV) 수분 보급 요법 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 남미 : 국가별 분석
제10장 중동 및 아프리카의 정맥내(IV) 수분 보급 요법 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 중동 및 아프리카 : 국가별 분석
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)
제11장 시장 역학
제12장 시장 동향과 발전
제13장 PESTEL 분석
제14장 Porter의 Five Forces 분석
- 업계내 경쟁
- 신규 참여 가능성
- 공급업체의 힘
- 고객의 힘
- 대체품의 위협
제15장 경쟁 구도
- Core IV Therapy, LLC
- Cryojuvenate UK Ltd.
- B. Braun Medical Inc.
- Otsuka Pharmaceutical Co., Ltd.
- NexGen Health Inc
- JW Life Science Corporation
- Amanta Healthcare Ltd
- Baxter International Inc.
- Drip Hydration Inc
- Becton, Dickinson and Company
제16장 전략적 제안
제17장 회사 소개 및 면책조항
LSH
Global Intravenous (IV) Hydration Therapy Market was valued at USD 3.26 Billion in 2024 and is expected to reach USD 4.98 Billion by 2030 with a CAGR of 7.32% during the forecast period. Intravenous (IV) Hydration Therapy is a medical treatment that involves delivering fluids, electrolytes, and sometimes medications directly into a person's bloodstream through a vein. It is commonly used to address dehydration and various medical conditions. Intravenous (IV) hydration is often employed to treat moderate to severe dehydration, which can occur due to illnesses, excessive sweating, vomiting, diarrhoea, or inadequate fluid intake. IV fluids quickly replenish the body's fluid levels, helping to restore electrolyte balance and maintain proper organ function. IV hydration therapy can help manage the fluid and electrolyte imbalances that can arise from certain illnesses, such as gastroenteritis, kidney infections, and urinary tract infections. Electrolytes are essential minerals (such as sodium, potassium, calcium, and magnesium) that play a crucial role in maintaining various bodily functions, including nerve and muscle function, fluid balance, and pH regulation. IV hydration therapy can correct imbalances in electrolyte levels, which can be caused by conditions like kidney dysfunction, hormonal disorders, or severe vomiting and diarrhoea.
| Market Overview |
|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 3.26 Billion |
| Market Size 2030 | USD 4.98 Billion |
| CAGR 2025-2030 | 7.32% |
| Fastest Growing Segment | Medicated segment |
| Largest Market | North America |
Key Market Drivers
Increasing Surgical Procedures Drives the Market Growth
Increasing surgical procedures drive the growth of the global Intravenous (IV) hydration therapy market primarily due to the essential role that IV hydration therapy plays in supporting patients before, during, and after surgical interventions. Surgical procedures can lead to fluid and electrolyte imbalances, making proper hydration and electrolyte management crucial for successful outcomes and patient recovery. Prior to surgery, patients often need to fast or restrict their oral fluid intake, which can lead to dehydration. IV hydration therapy is used to ensure that patients are adequately hydrated before surgery, which is important for maintaining stable blood pressure, optimal organ function, and overall patient well-being. During surgery, patients may experience fluid and electrolyte shifts due to blood loss, fluid shifts, and the effects of anaesthesia. IV hydration therapy helps maintain appropriate hydration levels and electrolyte balance, supporting the body's ability to respond to surgical stress and anaesthesia. After surgery, patients may experience nausea, vomiting, and limited oral intake, which can lead to further dehydration. IV hydration therapy is essential for supporting the recovery process, preventing complications, and facilitating the healing process. Proper hydration and electrolyte balance are key factors in reducing the risk of postoperative complications, such as infections, wound healing issues, and organ dysfunction. IV hydration therapy can help minimize these risks and improve overall patient outcomes. Adequate hydration and electrolyte balance are associated with faster healing and recovery times. IV hydration therapy can help patients regain their strength and energy more quickly after surgery, allowing them to resume normal activities sooner.
Key Market Challenges
Regulatory and Legal Considerations
Regulatory and legal considerations pose significant challenges to the global Intravenous (IV) hydration therapy market due to the need to ensure patient safety, maintain quality standards, and adhere to local and international regulations governing medical practices and the administration of medical treatments. Healthcare providers who administer IV hydration therapy need to hold the appropriate licenses and certifications to perform medical procedures. These requirements vary by jurisdiction and can involve extensive training and education. Obtaining and maintaining these credentials can be time-consuming and costly. Different healthcare professionals have varying scopes of practice when it comes to administering IV therapies. Legal and regulatory frameworks may restrict who is allowed to perform IV therapy, which can impact the availability and accessibility of the treatment.
Key Market Trends
Rise of Wellness and Lifestyle Use
In global Intravenous (IV) Hydration Therapy market, The rise of wellness and lifestyle use is a significant trend in the global Intravenous (IV) hydration therapy market. This trend involves individuals seeking IV hydration therapy not only for medical reasons but also for general wellness, lifestyle enhancement, and performance optimization. The trend has expanded the potential consumer base beyond traditional medical indications. Wellness-conscious individuals, athletes, professionals with demanding lifestyles, and those seeking quick recovery from fatigue or exertion are exploring IV hydration therapy for its perceived benefits. The trend aligns with a growing interest in holistic health and well-being. Consumers are viewing IV hydration therapy as a complementary approach to maintaining overall health, alongside other wellness practices such as diet, exercise, and stress management. Many individuals seek IV hydration therapy to boost energy levels and combat fatigue. The treatment is believed to provide a quick and efficient way to rehydrate and replenish essential nutrients, leading to improved vitality and performance. IV hydration therapy is often marketed as a way to support the immune system, particularly during times of stress, travel, or exposure to illness. Consumers may opt for IV treatments to enhance their body's defenses and well-being. IV hydration therapy is perceived as a convenient and time-efficient method of receiving hydration and nutrients. This appeals to busy individuals who seek immediate results.
Key Market Players
- Core IV Therapy, LLC
- Rejuvenated UK Ltd.
- B. Braun Medical Inc.
- Otsuka Pharmaceutical Co., Ltd.
- NexGen Health Inc
- JW Life Science Corporation
- Amanta Healthcare Ltd
- Baxter International Inc.
- Drip Hydration Inc.
- Becton, Dickinson and Company
Report Scope:
In this report, Global Intravenous (IV) Hydration Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Intravenous (IV) Hydration Therapy Market, By Service:
- Immune Boosters
- Energy Boosters
- Skin Care
- Migraine
- Others
Intravenous (IV) Hydration Therapy Market, By Component:
Intravenous (IV) Hydration Therapy Market, By End-User:
- Hospitals & Clinics
- Wellness Centers & Spas
- Home Healthcare
- Others
Intravenous (IV) Hydration Therapy Market, By region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- South Korea
- Australia
- Japan
- Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Intravenous (IV) Hydration Therapy Market.
Available Customizations:
Global Intravenous (IV) Hydration Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Intravenous (IV) Hydration Therapy Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Service (Immune Boosters, Energy Boosters, Skin Care, Migraine, Others)
- 5.2.2. By Component (Medicated, Non-medicated)
- 5.2.3. By End-Use Industry (Hospitals & Clinics, Wellness Centers & Spas, Home Healthcare, Others)
- 5.2.4. By Company (2024)
- 5.2.5. By Region
- 5.3. Market Map
6. North America Intravenous (IV) Hydration Therapy Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Service
- 6.2.2. By Component
- 6.2.3. By End-Use Industry
- 6.2.4. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Intravenous (IV) Hydration Therapy Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Service
- 6.3.1.2.2. By Component
- 6.3.1.2.3. By End-Use Industry
- 6.3.2. Mexico Intravenous (IV) Hydration Therapy Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Service
- 6.3.2.2.2. By Component
- 6.3.2.2.3. By End-Use Industry
- 6.3.3. Canada Intravenous (IV) Hydration Therapy Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Service
- 6.3.3.2.2. By Component
- 6.3.3.2.3. By End-Use Industry
7. Europe Intravenous (IV) Hydration Therapy Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Service
- 7.2.2. By Component
- 7.2.3. By End-Use Industry
- 7.2.4. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. France Intravenous (IV) Hydration Therapy Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Service
- 7.3.1.2.2. By Component
- 7.3.1.2.3. By End-Use Industry
- 7.3.2. Germany Intravenous (IV) Hydration Therapy Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Service
- 7.3.2.2.2. By Component
- 7.3.2.2.3. By End-Use Industry
- 7.3.3. United Kingdom Intravenous (IV) Hydration Therapy Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Service
- 7.3.3.2.2. By Component
- 7.3.3.2.3. By End-Use Industry
- 7.3.4. Italy Intravenous (IV) Hydration Therapy Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Service
- 7.3.4.2.2. By Component
- 7.3.4.2.3. By End-Use Industry
- 7.3.5. Spain Intravenous (IV) Hydration Therapy Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Service
- 7.3.5.2.2. By Component
- 7.3.5.2.3. By End-Use Industry
8. Asia-Pacific Intravenous (IV) Hydration Therapy Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Service
- 8.2.2. By Component
- 8.2.3. By End-Use Industry
- 8.2.4. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Intravenous (IV) Hydration Therapy Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Service
- 8.3.1.2.2. By Component
- 8.3.1.2.3. By End-Use Industry
- 8.3.2. India Intravenous (IV) Hydration Therapy Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Service
- 8.3.2.2.2. By Component
- 8.3.2.2.3. By End-Use Industry
- 8.3.3. South Korea Intravenous (IV) Hydration Therapy Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Service
- 8.3.3.2.2. By Component
- 8.3.3.2.3. By End-Use Industry
- 8.3.4. Japan Intravenous (IV) Hydration Therapy Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Service
- 8.3.4.2.2. By Component
- 8.3.4.2.3. By End-Use Industry
- 8.3.5. Australia Intravenous (IV) Hydration Therapy Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Service
- 8.3.5.2.2. By Component
- 8.3.5.2.3. By End-Use Industry
9. South America Intravenous (IV) Hydration Therapy Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Service
- 9.2.2. By Component
- 9.2.3. By End-Use Industry
- 9.2.4. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Intravenous (IV) Hydration Therapy Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Service
- 9.3.1.2.2. By Component
- 9.3.1.2.3. By End-Use Industry
- 9.3.2. Argentina Intravenous (IV) Hydration Therapy Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Service
- 9.3.2.2.2. By Component
- 9.3.2.2.3. By End-Use Industry
- 9.3.3. Colombia Intravenous (IV) Hydration Therapy Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Service
- 9.3.3.2.2. By Component
- 9.3.3.2.3. By End-Use Industry
10. Middle East and Africa Intravenous (IV) Hydration Therapy Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Service
- 10.2.2. By Component
- 10.2.3. By End-Use Industry
- 10.2.4. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Intravenous (IV) Hydration Therapy Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Service
- 10.3.1.2.2. By Component
- 10.3.1.2.3. By End-Use Industry
- 10.3.2. Saudi Arabia Intravenous (IV) Hydration Therapy Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Service
- 10.3.2.2.2. By Component
- 10.3.2.2.3. By End-Use Industry
- 10.3.3. UAE Intravenous (IV) Hydration Therapy Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Service
- 10.3.3.2.2. By Component
- 10.3.3.2.3. By End-Use Industry
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Recent Developments
- 12.2. Product Launches
- 12.3. Mergers & Acquisitions
13. PESTLE Analysis
14. Porter's Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Product
15. Competitive Landscape
- 15.1. Core IV Therapy, LLC
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (In case of listed companies)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
- 15.2. Cryojuvenate UK Ltd.
- 15.3. B. Braun Medical Inc.
- 15.4. Otsuka Pharmaceutical Co., Ltd.
- 15.5. NexGen Health Inc
- 15.6. JW Life Science Corporation
- 15.7. Amanta Healthcare Ltd
- 15.8. Baxter International Inc.
- 15.9. Drip Hydration Inc
- 15.10. Becton, Dickinson and Company
16. Strategic Recommendations
17. About Us & Disclaimer
